A genome‐wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q

Summary.  Objectives:  To identify venous thromboembolism (VTE) disease‐susceptibility genes.

[1]  F. Cambien,et al.  Genetics of Venous Thrombosis: Insights from a New Genome Wide Association Study , 2011, PloS one.

[2]  Sebastian M. Armasu,et al.  Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism , 2011, Journal of thrombosis and haemostasis : JTH.

[3]  A. Nurden.  Platelets, inflammation and tissue regeneration , 2011, Thrombosis and Haemostasis.

[4]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[5]  Eric Boerwinkle,et al.  The gene, environment association studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions , 2010, Genetic epidemiology.

[6]  R. O'Kennedy,et al.  Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. , 2010, Blood.

[7]  Ming-Huei Chen,et al.  Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium , 2010, Circulation.

[8]  Kevin P. Murphy,et al.  SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors , 2010, Bioinform..

[9]  K. Bailey,et al.  Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism?: A Population-Based Case–Control Study , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[10]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[11]  E. Boerwinkle,et al.  SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI Study. , 2009, Clinical chemistry.

[12]  S. Heath,et al.  Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. , 2009, Blood.

[13]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[14]  K. Gomes,et al.  Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[15]  T. Lumley,et al.  ABO genotype and risk of thrombotic events and hemorrhagic stroke , 2009, Journal of thrombosis and haemostasis : JTH.

[16]  G. Abecasis,et al.  Genotype imputation. , 2009, Annual review of genomics and human genetics.

[17]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[18]  D. Tregouet,et al.  P‐selectin polymorphisms’ influences on P‐selectin serum concentrations and on their familial correlation: the STANISLAS family study , 2008, Journal of thrombosis and haemostasis : JTH.

[19]  F. Rosendaal,et al.  Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation , 2008, Journal of thrombosis and haemostasis : JTH.

[20]  J. Heit,et al.  The epidemiology of venous thromboembolism in the community. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[22]  A. Folsom,et al.  ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) , 2007, Journal of thrombosis and haemostasis : JTH.

[23]  O. Wagner,et al.  Circulating P-selectin and the risk of recurrent venous thromboembolism , 2007, Thrombosis and Haemostasis.

[24]  J. Heit.  Thrombophilia: Clinical and Laboratory Assessment and Management , 2007 .

[25]  W. O.  ABO ( H ) blood groups and vascular disease : a systematic review and meta-analysis , 2007 .

[26]  Pablo Villoslada,et al.  European Population Substructure: Clustering of Northern and Southern Populations , 2006, PLoS genetics.

[27]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[28]  S. Batzoglou,et al.  Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.

[29]  R. Pullmann,et al.  More on: thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population‐based case–control study , 2005, Journal of thrombosis and haemostasis : JTH.

[30]  M. de Andrade,et al.  Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population‐based case–control study , 2005, Journal of thrombosis and haemostasis : JTH.

[31]  E. Oger,et al.  Phenotypic but not allelic ABO blood group association with risk of venous thrombosis , 2005, Thrombosis and Haemostasis.

[32]  J. Heit,et al.  The incidence of venous thromboembolism among Factor V Leiden carriers: a community‐based cohort study , 2005, Journal of thrombosis and haemostasis : JTH.

[33]  J. Fontcuberta,et al.  The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism , 2005, Thrombosis and Haemostasis.

[34]  F. Rosendaal,et al.  ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden , 2005, Journal of thrombosis and haemostasis : JTH.

[35]  P. Andre.  P‐selectin in haemostasis , 2004, British journal of haematology.

[36]  M. de Andrade,et al.  Familial segregation of venous thromboembolism , 2004, Journal of thrombosis and haemostasis : JTH.

[37]  P. Schnohr,et al.  Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population , 2004, Annals of Internal Medicine.

[38]  J. Vaupel,et al.  Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins , 2003, Epidemiology.

[39]  A. Folsom,et al.  Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.

[40]  F. Rosendaal,et al.  High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene , 2001, British journal of haematology.

[41]  L. Almasy,et al.  Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. , 2000, American journal of human genetics.

[42]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[43]  W M O'Fallon,et al.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.

[44]  F. Rosendaal,et al.  Increased soluble P‐selectin levels following deep venous thrombosis: cause or effect? , 2000, British journal of haematology.

[45]  L. Melton,et al.  Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. , 1999, Archives of internal medicine.

[46]  J. Griffin,et al.  A single genetic origin for a common Caucasian risk factor for venous thrombosis. , 1997, Blood.

[47]  P. Mannucci,et al.  Heightened Thrombin Generation in Individuals with Resistance to Activated Protein C , 1996, Thrombosis and Haemostasis.

[48]  J. Felsenstein,et al.  A Hidden Markov Model approach to variation among sites in rate of evolution. , 1996, Molecular biology and evolution.

[49]  K. Mann,et al.  Characterization of the Molecular Defect in Factor VR506A(*) , 1995, The Journal of Biological Chemistry.

[50]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[51]  B. Dahlbäck,et al.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K. Titani,et al.  Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. , 1992, The Journal of biological chemistry.